Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Kane Biotech Inc. V.KNE

Alternate Symbol(s):  KNBIF

Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, DermaKB and DermaKB Biofilm are trademarks of the company. The firm is also engaged in the animal health businessthrough its Stem Animal Health subsidiary.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

Great read on biotech sector!

https://biotechstocktrends.com/plant-based-crop-spray-killing-it/?utm_source=mcnalliemoney&utm_medium=influencer&utm_campaign=bbbtz_us  rate and reply

Important Quote

" Kane is collaborating with the FDA on our coactiv+™ 510(k) application for which a positive pre-submission meeting was recently held and a clear path forward was established" This...read more

Kane Biotech to close fully subscribed private placement

https://themarketherald.ca/kane-biotech-announces-update-on-private-placement-2022-05-06/  rate and reply

Insider buying

Kane Biotech Announces Update on Private Placement   May 06, 2022 08:30 ET  | Source: Kane Biotech Inc.   ...read more

RE:RE:Halted

Despite the high volume dump post news, the validation flowing from the certification and subsequent tangible increased revenue flows is significant and lowers the investment risk.   rate and reply

RE:Halted

And not a very exciting news release.  rate and reply

Halted

Pending news  rate and reply

RE:RE:RE:RE:RE:RE:Kane Biotech Announces New Collaboration Agreements

I like this CEO, he has surrounded himself with competent people and is unafraid to shift the reigns to them. There is a definitive direction for the company in niche space, with contracts in place...read more

RE:RE:RE:RE:RE:Kane Biotech Announces New Collaboration Agreements

no problem.  Kane has another patent appliction published  Bibliographic data: US2022054383 (A1) 2022-02-24 |   In my patents list | Previous ...read more

RE:RE:RE:RE:Kane Biotech Announces New Collaboration Agreements

Yes your right, I missed it. Happy and rieved to see it actually, a BioTech implementing a business plane with targeted segments. Just never stood out for me and I remember reading the management...read more

RE:RE:RE:Kane Biotech Announces New Collaboration Agreements

also it was plainly in this statment from 2nd Q 2021 MD&A  released Aug 26th 2021 which is the same statement made on the year end 2020 MD&A released Mar 25th 2021....frankly surprised...read more

RE:RE:Kane Biotech Announces New Collaboration Agreements

mirrirworldman take a look at this at 3:44 in...the slide from a prevoius/ old presentation plainly shows the prosthetic joints etc issue as a target. Also at the end at 7:00 gives some of the many...read more

RE:Kane Biotech Announces New Collaboration Agreements

Looks like an investigator initiated trial designed to flow cash to the doctor and perhaps supply a tiny bit of human evidence to Kane.  Its odd that this market did not come up on the Radar of...read more

Kane Biotech Announces New Collaboration Agreements

WINNIPEG, Manitoba, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces that it has signed collaboration agreements with Dr. James Doub, MD, Assistant Professor of Medicine, University of...read more

Volume is picking up...a little

Daily and weekly volume (all stock exchanges) is picking up. We are well overdue for an update regarding the following topics; 1. Animalcare (sales and production); 2. New veterinarian certification...read more

Summary

https://www.rally-co.ca/post/kne-v-undervalued  rate and reply

STEM

Snippets related to STEM from AnimalCares Group’s recent release.   28 September 2021. Animalcare Group plc ("the Company" or "Group") (AIM: ANCR), the...read more

yet another DispersinB patent application published

https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20210910&CC=WO&NR=2021174351A1&KC=A1 Bibliographic data...read more

STABLE LIQUID DISPERSINB COMPOSITIONS

new patent application filed  STABLE LIQUID DISPERSINB COMPOSITIONS  https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D...read more

RE:RE:PetSmart Canada(R) - Latest news

Tell all your friends with pets, especially the ones brushing their dog's or cat's teeth.       rate and reply